Limin X. Yang
Key Laboratory Of Pathogenic Microbiology And Immunology
Beijing, 100101, China
Beijing, 100101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Laser-Induced Periodic Nanostructure on Polyimide Film Surface Using 248 nm Excimer Laser.
Journal: Nanomaterials (Basel, Switzerland)
Published: April 02, 2025
An evolutionary game theory analysis on the environmental impact of discharging Fukushima's nuclear wastewater: International stakeholders and strategic dynamics.
Journal: PloS one
Published: March 21, 2024
Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.
Journal: Frontiers in medicine
Published: September 26, 2023
Preparation and immunogenicity evaluation of mRNA vaccine against porcine epidemic diarrhea
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: August 16, 2023
Zeolitic Imidazolate Framework-8 (ZIF-8) as a Drug Delivery Vehicle for the Transport and Release of Telomerase Inhibitor BIBR 1532.
Journal: Nanomaterials (Basel, Switzerland)
Published: May 10, 2023
The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs.
Journal: Frontiers in immunology
Published: March 17, 2022
A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection.
Journal: Vaccines
Published: December 30, 2021
Nasal delivery of thermostable and broadly neutralizing antibodies protects mice against SARS-CoV-2 infection.
Journal: Signal transduction and targeted therapy
Published: November 24, 2021
Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation.
Journal: Innovation (Cambridge (Mass.))
Published: June 29, 2021
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice.
Journal: Signal transduction and targeted therapy
Published: June 10, 2021
A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.
Journal: Innovation (Cambridge (Mass.))
Published: March 31, 2021
Last Updated: 09/26/2026